glutathione disulfide has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, SB; Hsiao, YF; Huang, SC; Huang, YC; Lai, CY; Liu, HT | 1 |
| Abe, M; Hatakeyama, K; Kami, K; Kinugasa, Y; Kusuhara, M; Mochizuki, T; Sugino, T; Terashima, M; Yamaguchi, K; Yamakawa, Y | 1 |
2 other study(ies) available for glutathione disulfide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma.
Topics: Aged; Antioxidants; Carcinoma, Hepatocellular; Cross-Sectional Studies; Female; Follow-Up Studies; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Hepatectomy; Humans; Liver Neoplasms; Male; Malondialdehyde; Middle Aged; Neoplasm Recurrence, Local; Oxidative Stress; Oxygen Radical Absorbance Capacity; Postoperative Period; Predictive Value of Tests; Prognosis | 2021 |
CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
Topics: Aged; Biomarkers, Tumor; Female; Glutathione; Glutathione Disulfide; Humans; Hyaluronan Receptors; Male; Metabolome; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Reactive Oxygen Species; Stomach Neoplasms; Survival Rate | 2017 |